Aptose Biosciences Inc. (TSE:APS - Get Free Report) NASDAQ: APTO's share price crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$2.01 and traded as high as C$2.19. Aptose Biosciences shares last traded at C$2.05, with a volume of 10,614 shares changing hands.
Aptose Biosciences Stock Performance
The company has a debt-to-equity ratio of -117.37, a quick ratio of 5.41 and a current ratio of 1.05. The company has a market cap of C$72.34 million, a P/E ratio of -0.33 and a beta of 1.36. The firm has a 50 day moving average price of C$1.97 and a 200-day moving average price of C$3.98.
Aptose Biosciences Company Profile
(
Get Free Report)
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
See Also
Before you consider Aptose Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aptose Biosciences wasn't on the list.
While Aptose Biosciences currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access